Extra Cancer Care

Product Features

Comprehensive Benefit up to $9,000,000

View More

• Provides the most comprehensive cancer benefit, from diagnostic investigation and medical treatment to ongoing monitoring after treatment
• Offers a maximum lifetime limit of as much as HK$/MOP9,000,000, with full reimbursement¹ of the actual medical expenses for diagnosis and treatment
• Offers an array of extra care and cash benefits.
• Please refer to the product factsheet for details.

Notes:

^1. Reimbursement will be based on a "Reasonable and Customary" basis, i.e., treatment and procedures that are Medically Necessary and do not exceed the general level of charges at the location for such treatment and procedure.

Extra Cash Benefit

View More

• Hospital Cash: Maximum HK$/MOP1,000 daily; double benefit for Confinement in Intensive Care Unit
• Monthly Living Benefit²: Maximum HK$/MOP30,000 monthly for up to 12 months

Notes:

^2. Applicable to the first diagnosis of a Later-stage Cancer and while the Insured is still alive.

Worldwide Coverage

View More

• Provides worldwide coverage³ that applies to any Hospital, day case unit of a Hospital, Cancer Clinic worldwide and clinic in Hong Kong/Macau

Notes:

^3. The maximum aggregate benefit payable for Cancer treatment charges incurred in the US including Hospitalization Benefit, Surgical Benefit, Medical Treatment Benefit, as well as the Medical Consultation and Diagnostic Benefit for all Extra Cancer Care and Extra Cancer Benefit issued by the Company under the same Insured will be up to HK$2,000,000 Per Cancer.

Lifetime Guaranteed Renewal

View More

• With a benefit term of up to age 100 of the Insured
• The annual renewal premium will be adjusted based on the attained age of the Insured and at the premium rate in effect of the same level of benefit at the time of renewal

Multiple Cancer Benefits

View More

• The plan provides comprehensive coverage in case of multiple Cancers.
• Provided that the period elapsed between the diagnosis dates of the two different Cancers (whether they occur in the same or a different organ) is one year or more, the subsequent Cancer is considered as another Cancer.
• If the subsequent Cancer is a recurrence or metastasis of the Relevant Preceding Cancer, provided that the period elapsed between the diagnosis dates of the subsequent Cancer and the Relevant Preceding Cancer is five years or more, and the Relevant Preceding Cancer was once in complete remission during such period, the subsequent Cancer is considered as another Cancer.
• Otherwise, it is considered as a continuation of the Preceding Cancer, i.e., the benefit will be paid under the same Cancer